GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Current Deferred Taxes Liabilities

VRBCF (Virbac) Current Deferred Taxes Liabilities : $0 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Virbac Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Virbac's current deferred tax liabilities for the quarter that ended in Dec. 2024 was $0 Mil.

Virbac Current Deferred Taxes Liabilities Historical Data

The historical data trend for Virbac's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Current Deferred Taxes Liabilities Chart

Virbac Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Virbac Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Virbac Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Virbac's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac Business Description

Industry
Traded in Other Exchanges
Address
13e rue LID - BP 27, Carros, FRA, 06511
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacific, and Latin America.

Virbac Headlines

From GuruFocus

Half Year 2024 Virbac SA Earnings Call Transcript

By GuruFocus Research 09-17-2024

Half Year 2020 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Half Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2019 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Virbac SA SFAF Meeting Transcript

By GuruFocus Research 03-08-2024

Full Year 2021 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024

Full Year 2018 Virbac SA Earnings Call Transcript

By GuruFocus Research 03-08-2024